Jain A K, Vargas R, Gotzkowsky S, McMahon F G
Clinical Research Center, New Orleans, Louisiana 70112.
Am J Med. 1993 Jun;94(6):632-5. doi: 10.1016/0002-9343(93)90216-c.
To assess the effects of standardized garlic powder tablets on serum lipids and lipoproteins, glucose, and blood pressure.
Forty-two healthy adults (19 men, 23 women), mean age of 52 +/- 12 years, with a serum total cholesterol (TC) level of greater than or equal to 220 mg/dL received, in a randomized, double-blind fashion, either 300 mg three times a day of standardized garlic powder in tablet form or placebo. Diets and physical activity were unchanged. This study was conducted in an outpatient, clinical research unit.
The baseline serum TC level of 262 +/- 34 mg/dL was reduced to 247 +/- 40 mg/dL (p < 0.01) after 12 weeks of standard garlic treatment. Corresponding values for placebo were 276 +/- 34 mg/dL before and 274 +/- 29 mg/dL after placebo treatment. Low-density lipoprotein cholesterol (LDL-C) was reduced by 11% by garlic treatment and 3% by placebo (p < 0.05). There were no significant changes in high-density lipoprotein cholesterol, triglycerides, serum glucose, blood pressure, and other monitored parameters.
Treatment with standardized garlic 900 mg/d produced a significantly greater reduction in serum TC and LDL-C than placebo. The garlic formulation was well tolerated without any odor problems.
评估标准化大蒜粉片对血脂、脂蛋白、血糖和血压的影响。
42名健康成年人(19名男性,23名女性),平均年龄52±12岁,血清总胆固醇(TC)水平大于或等于220mg/dL,以随机、双盲方式接受每日三次、每次300mg的标准化大蒜粉片或安慰剂。饮食和体力活动保持不变。本研究在门诊临床研究单位进行。
标准大蒜治疗12周后,基线血清TC水平从262±34mg/dL降至247±40mg/dL(p<0.01)。安慰剂组治疗前为276±34mg/dL,治疗后为274±29mg/dL。大蒜治疗使低密度脂蛋白胆固醇(LDL-C)降低11%,安慰剂使LDL-C降低3%(p<0.05)。高密度脂蛋白胆固醇、甘油三酯、血清葡萄糖、血压及其他监测参数无显著变化。
每日服用900mg标准化大蒜治疗比安慰剂能更显著降低血清TC和LDL-C。大蒜制剂耐受性良好,无任何气味问题。